Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients..
Nephrol Dial Transplant. 34(3), 515-523.
(2019). Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME..
Nat Rev Endocrinol. 13(6), 365-374.
(2017). Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes..
N Engl J Med. 374(11), 1092.
(2016). Early patterns of blood pressure change and future coronary atherosclerosis..
JAMA. 311(5), 471-2.
(2014). Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives..
Curr Pharm Des. 24(46), 5528-5536.
(2018). Renin-angiotensin-aldosterone system blockade in hypertensive patients with chronic kidney disease..
Blood Press. 22(6), 397-8.
(2013). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections..
Ann Intern Med. 171(12), 943-944.
(2019). Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy..
Expert Opin Drug Saf. 9(2), 259-73.
(2010). Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates..
Intensive Care Med. 36(5), 864-8.
(2010). Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. A pilot study..
Pediatr Nephrol. 29(2), 305-10.
(2014). Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients..
J Hypertens. 36(5), 1076-1085.
(2018). Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy..
Nat Rev Nephrol. 6(8), 447-9.
(2010). Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?.
Diabetes Care. 43(8), 1684-1686.
(2020). Targeted urine metabolomics in preterm neonates with intraventricular hemorrhage..
J Chromatogr B Analyt Technol Biomed Life Sci. 1104, 240-248.
(2019). Epidemiology of resistant hypertension..
J Clin Hypertens (Greenwich). 13(7), 523-8.
(2011). Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?.
Am J Nephrol. 46(4), 285-287.
(2017). Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?.
Nephrol Dial Transplant. 32(8), 1402-1409.
(2017). Comparable effect of conventional ventilation versus early high-frequency oscillation on serum CC16 and IL-6 levels in preterm neonates..
J Perinatol. 31(2), 104-11.
(2011). The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?.
Clin Kidney J. 13(1), 24-26.
(2020). Blood pressure targets for patients with chronic kidney disease..
Blood Press. 22(6), 395-6.
(2013). Daptomycin use in a neonate: serum level monitoring and outcome..
Am J Perinatol. 27(5), 421-4.
(2010). SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?.
Am J Nephrol. 51(7), 553-555.
(2020). Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis..
Am J Kidney Dis. 59(3), 434-8.
(2012). Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA..
Nephrol Dial Transplant. 33(10), 1872.
(2018). Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT..
Clin Kidney J. 13(3), 287-290.
(2020).